|
Eventual Acquisition Of Medicines For The Supply Of The Demands Of The Antineoplastic Therapy Sector Of The General Hospital Of Curitiba.. Abemaciclib, Abemaciclib, Abemaciclib, Enalabrutinibe, Alectinibe, Atezozumabe, Apalutamide, Azacitidine, Bevacizumabe, Bevacizumabe, Bendamustin, Belomostin, Blinatumomabe, Bortazomibe, Cabozantinibe, Carfilzomib, Carfilzomib , Cemiplimab, Cetuximab, Cetuximab, Cyclophosphamide, Dabrafenib, Dabrafenib , Dacarbazine, Daratumumab, Daratumumab, Daratumumab, Darolutamide, Dasatinib, Dasatinib, Decitabine, Denosumab, Doctaxel, Dostarlimab, Doxorrubicin Chloride, Doxorubicin, Durvalumab Mo, Eltrombopag Olamine, Afortumabe, Ecurinina Mesilate, Erlotinibe, Erlotinibe , Erlotinib, Ethoposide, Calcium Follicat, Fluoruracyl, Fosapoprepiopylumin, Flashing, Gencitabidin Hydrochloride, Gencitebralet, Gosserrelin Acetate, Gosserrelin, Granisetrone, Granisetrone, Ibrutinib, Ibrutinib, Vaccin, Vacin , Ipilimumab, Irinotecan Hydrochloride, Isatuximab, Isatuximab , Lapatinibe, Lenalyidomide, Lenalyidomide, Lenalyidomide, Letermovir, Letermovir, Lomustine, Lomustine, Lorlatinib, Lumlatinib, Megestrol Acetate, Metotrexate, Mesna, Micostaurin, Niglamab, Nilotinib, Nilotinib, Nilotinib Paribe, Nintedanib, Octreotida, Obinutuzumab, Olaparibe , Olaparibe, Osimertinib, Oxaliplatin, Paclitaxel, Paclitaxel, Palonosetrone Hydrochloride, Pazopanib
|
